1021/1664US=23 / Câncer
Hisaoka M, Hamada T. Sebaceous carcinoma of the breast: clinicopathologic features. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 29-32. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA SEBACEO DA MAMA; CARACTERISTICAS CLINICO-PATOLOGICAS

1022/1664US=28 / Biol/Mol
Kerbel RS, Emmenegger U, Folkins C, Munoz R, Shaked Y. Metronomic low-dose antiangiogenic chemotherapy in mice and man. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 277-96. ISBN 978-1-58829-870-6.

BAIXA DOSE DE QUIMIOTERAPIA; ANGIOGENESE TUMORAL; TERAPIA ANTIANGIOGENICA; ENSAIOS CLINICOS; CELULAS PROGENITORAS ENDOTELIAIS; VEGF; METASTASE; CANCER DE MAMA; CANCRO DO OVARIO; CICLOFOSFAMIDA

1023/1664US=23 / Câncer
Bach-Gansmo T, Tobin D. Breast cancer: detection by in-vivo imaging of angiogenesis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 33-42. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; ANGIOGENESE IN VIVO; INTEGRINAS; CINTILOGRAFIA; TC-NC100692; EXPERIENCIA CLINICA INICIAL; RAIOS GAMA; CAMARA GAMA

1024/1664US=23 / Câncer
Mattie MD, Getts RC. Breast and prostate biopsies: use of optimized high-throughput microRNA expression for diagnosis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 43-59. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DIAGNOSTICO; BIOPSIAS; USO DE EXPRESSAO DE MICRORNA; METODOLOGIA

1025/1664US=23 / Câncer
Bult P, Hoogerbrugge N. Familial breast cancer: detection of prevalent high-risk epithelial lesions. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 61-71. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA FAMILIAR; CARCINOMA LOBULAR IN SITU; HIPERPLASIA LOBULAR ATIPICA; CARCINOMA DUCTAL IN SITU; HIPERPLASIA DUCTAL ATIPICA

1026/1664US=23 / Câncer
Tang APY, Tse GMK, Lam WWM. Differentiation between benign and malignant papillary lesions of breast: excisional biopsy or stereotactic vacuum-assisted biopsy (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 73-97. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; LESOES BENIGNAS PAPILARES DE MAMA; LESOES MALIGNAS PAPILARES DE MAMA; BIOPSIA EXCISIONAL; BIOPSIA VACUO-ASSISTIDA; BIOPSIA ASSISTIDA POR VACUO; CARCINOMA DUCTAL; ASPIRACAO POR AGULHA FINA; BIOPSIA POR AGULHA; BIOPSIA EXCISIONAL; ESTEREOTAXIA; ULTRASSOM

1027/1664US=23 / Câncer
Knauer M, Konstantiniuk P, Haid A, Wenzl E, Koberle-Wuhrer R, Riegler-Keil M, Postlberger S, Reitsamer R, Schrenk P. Multicentric breast cancer: sentinel node biopsy as a diagnostic tool. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 99-108. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA MULTICENTRICO; BIOPSIA DE LINFONODO SENTINELA

1028/1664US=23 / Câncer
Lumachi F, Basso SMM, Basso U. Breast cancer recurrence: role of serum tumor markers CEA and CA 15-3. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 109-15. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CANCER DE MAMA RECORRENTE; PAPEL DO SORO; MARCADORES TUMORAIS; CEA; CA 15-3; ANTIGENO CARCINOEMBRIONARIO

1029/1664US=23 / Câncer
Zehentner BK. Breast cancer patients before, during or after treatment: circulating tumor cells in peripheral blood detected by multigene real-time reverse transcriptase-polymerase chain reaction. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 117-23. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CELULAS TUMORAIS CIRCULANTES; SANGUE PERIFERICO; REACAO MULTIGENICA EM TEMPO REAL; REACAO EM CADEIA DA POLIMERASE-TRANSCRIPTASE REVERSA

1030/1664US=23 / Câncer
Feng Q, Kiviat NB. Breast cancer patients: diagnostic epigenetic markers in blood. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 125-40. ISBN 978-1-4020-8368-6.

CANCER DE MAMA. DIAGNOSTICO; MARCADORES EPIGENETICOS NO SANGUE; ANALISE DE METILACAO; METILACAO-ESPECIFICA PCR; METODO DE REACAO EM CADEIA POR POLIMERASE; ANALISE DE DADOS

1031/1664US=23 / Câncer
Lin SR, Wang JY, Huang MY, Chen CC. Breast cancer patients: detection of circulating cancer cell-related mRNA markers with membrane array method. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 141-55. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; DETECCAO DE MARCADORES CIRCULANTES; METODO DE MATRIZ DE MRNA; METODO DE MATRIZ DE MEMBRANA; REACAO DA TRANSCRIPTASE REVERSA

1032/1664US=23 / Câncer
Yie SM. Prediction of metastasis and recurrence of breast carcinoma: detection of survivin-expressing circulating cancer cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 157-74. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; METASTASES; CARCINOMA DA MAMA; SURVIVINA; REACAO EM CADEIA DE POLIMERASE; METODOLOGIA ELISA

1033/1664US=23 / Câncer
Xenidis N, Perrakis M, Kakolyris S, Mavroudis D, Georgoulias V. Node-negative breast cancer: predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 175-88. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOQUERATINA-19-MRNA POSITIVOS; CELULAS TUMORAIS CIRCULANTES

1034/1664US=23 / Câncer
Bianco C, Strizzi L, De Luca A, Normanno N, Salomon DS. Breast and colon carcinomas: detection with plasma CRIPTO-1. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 189-202. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMAS DE MAMA; CARCINOMA DE COLON; PLASMA CRIPTO-1; TUMORIGENESE; ELISA

1035/1664US=23 / Câncer
Baltzell K, Mills D, Ljung BM, Love S, Wrensch M. Breast cancer risk in women with abnormal cytology in nipple aspirate fluid. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 203-16. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CITOLOGIA ANORMAL; FLUIDO ASPIRADO; AVALIACAO DE RISCO; DUCTO MAMARIO. ANATOMIA; FLUIDO DO ASPIRADO DE MAMILO; NAF

1036/1664US=23 / Câncer
Mumenthaler SM, Yoon N, Li A, Mah V, Chang G, Nooraie F, Elshimali Y, Hanna S, Kim S, Horvath S, Apple S, Chia D, Seligson DB, Goodglick L. Tissue microarrays: construction and utilization for biomarker studies. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 217-34. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TISSUE MICROARRAYS (TMA); BIOMARCADORES; PROTOCOLOS DE MARCADORES; EXPRESSAO DE BIOMARCADORES; ANALISES DE DADOS; FERRAMENTAS ESTATISTICAS

1037/1664US=23 / Câncer
Kelly CMA, Ryan DN, Penny SA, Gallagher WM. Systematic validation of breast cancer biomarkers using tissue microarrays: from construction to image analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 235-50. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TISSUE MICROARRAYS (TMA); VALIDACAO SISTEMATICA DE BIOMARCADORES; CONSTRUCAO DA IMAGEM; ANALISE DE IMAGEM; PELLET CELULAR; IMUNOHISTOQUIMICA

1038/1664US=23 / Câncer
Tan PH, Tse GMK, Yip GWC, Bay BH. Phyllodes tumours of the breast: the role of immunohistochemistry in diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 251-62. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS

1039/1664US=23 / Câncer
Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA

1040/1664US=23 / Câncer
Tot T. Metaplastic breast carcinoma: detection using histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 275-90. ISBN 978-1-4020-8368-6.

CANCER DE MAMA; CARCINOMA DE MAMA METAPLASICO; HISTOLOGIA; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS; PROGNOSTICO

Primeira | Anterior | Próxima | Última